6 Analysts Have This to Say About DexCom
Portfolio Pulse from Benzinga Insights
DexCom (NASDAQ:DXCM) has received various analyst ratings in the last quarter, with 3 bullish, 1 somewhat bullish, and 2 indifferent. The average 12-month price target for DexCom, according to 6 analysts, is $142.17, an increase of 5.31% from the previous average of $135.00.
July 28, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
DexCom has received a mix of analyst ratings, with a majority being bullish. The average 12-month price target has increased, indicating a positive outlook.
Analyst ratings are a significant factor in influencing stock prices. The majority of the ratings for DexCom are bullish, which is a positive sign. Furthermore, the increase in the average 12-month price target suggests that analysts expect the stock price to rise, which could positively impact the stock in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100